This study is testing a new type of CAR T-cell therapy for adults with B-cell non-Hodgkin's lymphoma that has come back or not responded to standard treatments. The therapy uses a patient's own modified immune cells designed to attack two common targets on lymphoma cells (CD19 an…
Phase: PHASE1, PHASE2 • Sponsor: Han weidong • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC